Treatment adherence and patient retention in the first year of a Phase-IIIclinical trial for the treatment of multiple sclerosis

Citation
Dc. Mohr et al., Treatment adherence and patient retention in the first year of a Phase-IIIclinical trial for the treatment of multiple sclerosis, MULT SCLER, 5(3), 1999, pp. 192-197
Citations number
11
Categorie Soggetti
Neurology,"Neurosciences & Behavoir
Journal title
MULTIPLE SCLEROSIS
ISSN journal
13524585 → ACNP
Volume
5
Issue
3
Year of publication
1999
Pages
192 - 197
Database
ISI
SICI code
1352-4585(199906)5:3<192:TAAPRI>2.0.ZU;2-I
Abstract
The Purpose of this study was to examine the relationship between patient m anagement strategies employed by study Personnel, and patient retention and adherence to treatment in the first year of a Phase III clinical trial of interferon beto-1b for treatment of secondary progressive multiple sclerosi s (MS). Study staff from each of 35 sites were interviewed regarding patien t management practices. Sites which were rated as more empathetic, as insti lling a sense of purpose in the patient and promoting less formal relations hips with patients had high rates of adherence to treatment In addressing s pecific patient concerns, attention to patients' emotional status and patie nts' expectations of trial participation were related to better adherence.